Renjit Babu is a Global Regulatory Affairs Director at Amgen, bringing extensive regulatory expertise within the obesity therapeutic area. They previously served as a Global Regulatory Lead at Novo Nordisk, where they developed regulatory strategies for innovative obesity treatments and managed cross-functional teams. Renjit has a strong academic background, holding multiple degrees, including a Doctor of Medicine and a Master of Science in Public Health, alongside certifications in Good Clinical Practice and Good Manufacturing Practice. They are also multilingual, with proficiency in English, Danish, and three additional languages.
This person is not in the org chart
This person is not in any teams
This person is not in any offices